Objective-To identify biological and clinical predictors of acute kidney injury in subjects with acute lung injury.Design-Secondary data analysis from a multicenter, randomized clinical trial.
Setting-Intensive care units in ten university medical centers.Patients-A total of 876 patients enrolled in the first National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome Clinical Network trial.Interventions-Study subjects were randomized to receive a low tidal volume ventilation strategy and pharmacologic therapy with ketoconazole or lisofylline in a factorial design.
Measurements and MainResults-We tested the association of baseline levels of interleukin-6, interleukin-8, interleukin-10, von Willebrand factor, tumor necrosis factor-α, type I and II soluble tumor necrosis factor receptors (sTNFR-I and -II), protein C, plasminogen activator inhibitor-1 (PAI-1), surfactant protein-A, surfactant protein-D, and intracellular adhesion molecule-1 with subsequent acute kidney injury. Of 876 study participants who did not have endstage renal disease, 209 (24%) developed acute kidney injury, defined as a rise in serum creatinine of >50% from baseline over the first four study days. The 180-day mortality rate for subjects with acute kidney injury was 58%, compared with 28% in those without acute kidney injury (p < .001). Interleukin-6, sTNFR-I, sTNFR-II, and PAI-1 levels were independently associated with acute kidney injury after adjustment for demographics, interventions, and severity of illness. A combination of clinical and biological predictors had the best area under the receiver operating characteristic curve, and the contribution of sTNFR-I and PAI-1 to this model was highly significant (p = .0003). Dr. Chertow is a scientific advisor to RenaMed Biologic, Westborough, MA. The remaining authors have not disclosed any potential conflicts of interest.
NIH Public Access
Author ManuscriptCrit Care Med. Author manuscript; available in PMC 2012 March 5.
NIH-PA Author ManuscriptNIH-PA Author Manuscript
NIH-PA Author ManuscriptConclusions-Elevations in PAI-1, interleukin-6, and the sTNFRs in subjects with acute kidney injury suggest that disordered coagulation, inflammation, and neutrophil-endothelial interactions play important roles in the pathogenesis of acute kidney injury. The combination of these biological and clinical risk factors may have important and additive value in predictive models for acute kidney injury.
Keywordsacute kidney injury; acute lung injury; acute respiratory distress syndrome; biological marker; predictive value; interleukin-6; soluble tumor necrosis factor receptor; plasminogen activator inhibitor-1Acute kidney injury (also known as acute renal failure) in hospitalized patients is associated with high mortality, often 40-60% in the critical care setting (1-4). New therapies that reduce the morbidity and mortality of acute kidney injury are urgently needed. Dialysis only manages the symptoms, rather than treating the injury (5).An important limitation to the treatment of ...